About this trial
Ten years after our team's publication, practices have changed considerably in the management of severe cirrhotic patients. This study will analyse these practices in primary care hospitals and in a tertiary centre, and assess the impact of these changes on the prognosis of these patients.
The following hypotheses will be tested:
* Improvement in intensive care and overall prognosis compared with data from the literature prior to 2014 * Improved access to liver transplantation compared with the literature prior to 2014 * Improvement in intensive care unit practices (for example: application of recommendations published by learned societies concerning the intensive care unit management of patients with cirrhosis, access to comfort care, degree of clinical severity on admission to the intensive care unit, etc.). * Centre' effect: variability in the phenotype of patients admitted to intensive care depending on the technical facilities available and whether or not the hospital centre has access to TH.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients with cirrhosis admitted to intensive care between January 2014 and December 2024.
Trial design
Cohort
Retrospective
Treatments tested in this trial
observational study
Other interventionThis observational study aims to describe the clinical practices and the outcome of patients admitted in ICU.
Treatment groups
Trial outcomes
Primary outcomes
28-day survival
Secondary outcomes
Phenotype of patients admitted to intensive care
Overall survival
Survival without liver transplantation
Proportion of patients listed for liver transplantation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.